At the MAPS 2022 Global Annual Meeting, MAPS sits down to chat with José Borbolla, Global Executive Medical Director at Esai, and Augusto Grinspan, VP Medical Affairs and Head LATAM with Merck KGaA about developments in the practice and direction of Medical Affairs in Latin America. Augusto and José are also co-chairs of the MAPS Latin America Chapter.
One topic of discussion at the MAPS 2022 Global Annual Meeting was the role of Medical Affairs in patient engagement. Specifically, with patients taking more ownership decisions surrounding care, should Medical Affairs be engaging with patients and/or patient communities in a compliant way? To go even further, should Medical Affairs be the entity within the organization that "owns" patient engagement? Here, Marija Geertsen, VP of Medical Affairs at Lundbeck shares her opinion -- and the story of how her opinion changed during the course of the meeting.
As Medical Affairs professionals, it's easy to focus on the tasks that are right in front of us everyday. In this interview with Monica de Abadal, SVP and Head of Medical Affairs, North America we sat down at the MAPS 2022 Global Annual Meeting to take a step back. Here is how Medical Affairs benefits patients and society. Watch the full interview here.
This podcast, recorded at the MAPS 2022 Global Annual Meeting, addresses the unique position of Medical Affairs in the rare disease space & how our work in this area is essential for patient benefit.
This podcast previews the MAPS 2022 Global Annual Meeting session “How Medical Affairs can best support internal and external collaborations in patient engagement,” that details the unique role of Medical Affairs in patient engagement.
This course uses a faux product to introduce essential concepts of Patient Centricity including a comprehensive description of strategy.
Last month, Medical Affairs and clinical experts from six organizations came together to help make clinical trials more accessible to and better understood by people facing vitiligo. You can do this in your therapeutic area.
MAPS speaks with MyHealthTeams Cofounder and CEO, Eric Peacock, about how health communities can help the biopharmaceutical industry develop new products that truly make a difference in patients’ lives.
This session will provide a learning opportunity for our audience by providing background on FDA’s Offices of Minority Health and Health Equity, and Women’s Health:
Through generation of Medical Insights, MA enhances its “third pillar” role within the pharmaceutical company and demonstrates value as a key driver in activities directly affecting patient outcomes.